Soo Jin Lee

6346605, Feb 12, 2002

Mar 31, 1998

09/052089

Soo Young Lee - New York NY
Yongwon Choi - New York NY

The Rockfeller University - New York NY

C07K 1447

530350, 530351, 514 2

A novel component of the TRAF (TNF Receptor Associated Factor) signaling complex, designated TRIP (TRAF Interacting Protein) which associates with the TNFR2 or CD30 signaling complex through its interaction with the TRAF2 protein and influences signals responsible for cell activation, cell proliferation and cell death.

6900050, May 31, 2005

Nov 20, 2000

09/716536

Soo Young Lee - New York NY, US
Yongwon Choi - New York NY, US

The Rockefeller University - New York NY

C12N015/12
C12N005/10

4353201, 435325, 536 235

A novel component of the TRAF (TNF Receptor Associated Factor) signaling complex, designated TRIP (TRAF Interacting Protein) which associates with the TNFR2 or CD30 signaling complex through its interaction with the TRAF2 protein and influences signals responsible for cell activation, cell proliferation and cell death.

20050250177, Nov 10, 2005

Aug 7, 2003

10/637017

Faustinus Yeboah - Longueuil, CA
Barbara Jardin - Montreal, CA
Yasuo Konishi - Kirkland, CA
Amine Kamen - Montreal, CA
Tin Wong - Singapore, SG
Soo Lee - Horsham PA, US

C12P021/06
C12N005/02

435068100, 435404000

A process for preparing an active animal cell-growth-enhancing fraction of a hydrolysate of plant tissue, animal tissue or microorganism ultrafiltrate material, especially a fraction of a yeastolate ultrafiltrate, comprising forming a precipitate from said fraction with a water-soluble solvent is disclosed. Such solvents as alkanols, alkyl sulfoxides, ketones or alkyl nitriles, especially lower (C-C) alkanols, particularly ethanol, can be used. The invention also relates to an active animal cell-growth-enhancing fraction of a hydrolysate of plant tissue, animal tissue or microorganism ultrafiltrate material, especially a fraction of a yeastolate ultrafiltrate, substantially free of aromatic and methyl group bearing compounds which has improved cell-growth-enhancing properties.

20070111241, May 17, 2007

Oct 16, 2006

11/582008

Nezih Cereb - Ossining NY, US
Soo Lee - Ossining NY, US

C12Q 1/68
G06F 19/00

435006000, 702020000

The present invention relates to a system and method for accessing, tracking and editing sequence analysis and software to accomplish the same. The present invention includes embodiments that permit a party, for example a customer, to track the status of the samples (e.g., tissue, blood, or DNA) that the party sends for sequence based typing (“SBT”) analysis. The party can also participate in the analysis by accessing the sequencing data for the submitted samples. A party is able to remotely access tools for sequence based typing (e.g., Histomatcher), and using such tools, the party can review and edit the data. The party can also generate reports via the accessed tools.

20160359004, Dec 8, 2016

Jun 3, 2015

14/729741

- Plainview NY, US
George Papasouliotis - Warren NJ, US
Balakrishnan Krishnan - Bridgewater NJ, US
Soo Min Lee - Bridgewater NJ, US

H01L 29/15
H01L 29/205
H01L 29/20

Stress control using superlattice structures for epitaxy on base wafer substrates, including AlN/GaN superlattices for epitaxy of GaN on silicon {111} substrates. Crack-free GaN cap layers can be grown over superlattice structures containing AlN/GaN superlattice layers. Compressive and tensile stress can be precisely adjusted by changing the thickness of the superlattice layers and the number of superlattice layers. For a constant period thickness, growth conditions, such as growth rate of GaN, V/III ratio during AlN growth, and growth temperature, can be adjusted.